Concepts (97)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Uterine Rupture | 1 | 2023 | 67 | 0.830 |
Why?
|
| Oxytocics | 1 | 2023 | 67 | 0.830 |
Why?
|
| Vaginal Birth after Cesarean | 1 | 2023 | 65 | 0.800 |
Why?
|
| Sarcoma, Endometrial Stromal | 1 | 2018 | 92 | 0.560 |
Why?
|
| General Adaptation Syndrome | 1 | 2016 | 7 | 0.520 |
Why?
|
| Progestins | 1 | 2018 | 300 | 0.520 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2021 | 532 | 0.480 |
Why?
|
| Aromatase Inhibitors | 1 | 2018 | 518 | 0.450 |
Why?
|
| Papillomaviridae | 1 | 2018 | 1137 | 0.390 |
Why?
|
| Papillomavirus Vaccines | 1 | 2018 | 495 | 0.380 |
Why?
|
| Antihypertensive Agents | 1 | 2021 | 2033 | 0.370 |
Why?
|
| Guideline Adherence | 1 | 2021 | 2242 | 0.360 |
Why?
|
| Endometrial Neoplasms | 1 | 2018 | 1378 | 0.310 |
Why?
|
| Developmental Disabilities | 1 | 2016 | 1519 | 0.270 |
Why?
|
| Papillomavirus Infections | 1 | 2018 | 1638 | 0.260 |
Why?
|
| Anticonvulsants | 1 | 2016 | 1918 | 0.250 |
Why?
|
| Vaccination | 1 | 2018 | 3427 | 0.250 |
Why?
|
| Cesarean Section | 3 | 2023 | 1431 | 0.230 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2018 | 3230 | 0.220 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2016 | 2531 | 0.210 |
Why?
|
| Pregnancy | 10 | 2023 | 30248 | 0.200 |
Why?
|
| Trial of Labor | 1 | 2023 | 85 | 0.200 |
Why?
|
| Pregnancy Complications | 1 | 2016 | 2969 | 0.190 |
Why?
|
| Betamethasone | 1 | 2021 | 48 | 0.190 |
Why?
|
| Postpartum Hemorrhage | 1 | 2023 | 275 | 0.170 |
Why?
|
| Placenta Accreta | 1 | 2023 | 242 | 0.170 |
Why?
|
| Obstetric Labor, Premature | 1 | 2021 | 268 | 0.160 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2020 | 2185 | 0.150 |
Why?
|
| Pregnancy, Ectopic | 1 | 2018 | 146 | 0.140 |
Why?
|
| Obstetrics | 1 | 2023 | 680 | 0.130 |
Why?
|
| Endocarditis, Bacterial | 1 | 2020 | 434 | 0.130 |
Why?
|
| Endocarditis | 1 | 2020 | 349 | 0.130 |
Why?
|
| Carbamazepine | 1 | 2016 | 222 | 0.120 |
Why?
|
| Communicable Disease Control | 1 | 2020 | 856 | 0.110 |
Why?
|
| Triazines | 1 | 2016 | 306 | 0.110 |
Why?
|
| Valproic Acid | 1 | 2016 | 444 | 0.100 |
Why?
|
| Medical Records | 1 | 2018 | 1409 | 0.100 |
Why?
|
| Cicatrix | 1 | 2018 | 797 | 0.100 |
Why?
|
| Gynecology | 1 | 2018 | 535 | 0.100 |
Why?
|
| Premature Birth | 2 | 2021 | 1829 | 0.100 |
Why?
|
| Pharmaceutical Preparations | 1 | 2020 | 1084 | 0.100 |
Why?
|
| Ambulatory Care Facilities | 1 | 2018 | 939 | 0.100 |
Why?
|
| Glucocorticoids | 1 | 2021 | 2132 | 0.100 |
Why?
|
| Placenta | 1 | 2020 | 1728 | 0.090 |
Why?
|
| Combined Modality Therapy | 2 | 2018 | 8528 | 0.080 |
Why?
|
| Health Status Disparities | 1 | 2020 | 1880 | 0.080 |
Why?
|
| Female | 11 | 2023 | 395961 | 0.070 |
Why?
|
| Disease-Free Survival | 1 | 2018 | 6832 | 0.070 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 6499 | 0.070 |
Why?
|
| Analysis of Variance | 1 | 2016 | 6203 | 0.070 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2020 | 3674 | 0.060 |
Why?
|
| Adult | 7 | 2021 | 222974 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 1 | 2021 | 7424 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2021 | 22224 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3101 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3224 | 0.050 |
Why?
|
| Humans | 11 | 2023 | 765734 | 0.050 |
Why?
|
| Abortion, Therapeutic | 1 | 2020 | 35 | 0.040 |
Why?
|
| Obstetrics and Gynecology Department, Hospital | 1 | 2020 | 41 | 0.040 |
Why?
|
| Hospitalization | 1 | 2020 | 10806 | 0.040 |
Why?
|
| Epilepsy | 1 | 2016 | 3318 | 0.040 |
Why?
|
| Directive Counseling | 1 | 2021 | 171 | 0.040 |
Why?
|
| Abruptio Placentae | 1 | 2020 | 115 | 0.040 |
Why?
|
| Curettage | 1 | 2018 | 74 | 0.040 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2021 | 587 | 0.040 |
Why?
|
| Child | 2 | 2018 | 80499 | 0.040 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2020 | 685 | 0.040 |
Why?
|
| Hysteroscopy | 1 | 2018 | 63 | 0.040 |
Why?
|
| Potassium Chloride | 1 | 2018 | 229 | 0.040 |
Why?
|
| Abortifacient Agents, Nonsteroidal | 1 | 2018 | 65 | 0.040 |
Why?
|
| Uterine Balloon Tamponade | 1 | 2018 | 37 | 0.040 |
Why?
|
| Uterine Artery Embolization | 1 | 2018 | 62 | 0.040 |
Why?
|
| New York | 1 | 2020 | 880 | 0.040 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2020 | 737 | 0.040 |
Why?
|
| Tricuspid Valve | 1 | 2020 | 422 | 0.030 |
Why?
|
| Pregnancy Rate | 1 | 2018 | 655 | 0.030 |
Why?
|
| Young Adult | 2 | 2018 | 59852 | 0.030 |
Why?
|
| Watchful Waiting | 1 | 2018 | 493 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2016 | 42468 | 0.030 |
Why?
|
| Phylogeny | 1 | 2020 | 2836 | 0.030 |
Why?
|
| Gestational Age | 1 | 2021 | 3612 | 0.020 |
Why?
|
| RNA, Viral | 1 | 2020 | 2865 | 0.020 |
Why?
|
| Methotrexate | 1 | 2018 | 1721 | 0.020 |
Why?
|
| Viral Load | 1 | 2020 | 3385 | 0.020 |
Why?
|
| Pre-Eclampsia | 1 | 2020 | 1261 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2020 | 26332 | 0.020 |
Why?
|
| Adolescent | 1 | 2018 | 88781 | 0.020 |
Why?
|
| Pregnancy Outcome | 1 | 2020 | 2967 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2021 | 24279 | 0.020 |
Why?
|
| Recurrence | 1 | 2018 | 8498 | 0.020 |
Why?
|
| Comorbidity | 1 | 2020 | 10567 | 0.020 |
Why?
|
| Aged | 1 | 2018 | 171050 | 0.020 |
Why?
|
| Risk Factors | 2 | 2021 | 74831 | 0.010 |
Why?
|
| Middle Aged | 1 | 2018 | 222903 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8703 | 0.010 |
Why?
|
| Time Factors | 1 | 2021 | 40066 | 0.010 |
Why?
|
| Male | 1 | 2016 | 363585 | 0.010 |
Why?
|
Concepts
(97)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(8)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_